Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Gout management: let's get it right this time.

Sundy JS.

Arthritis Rheum. 2008 Nov 15;59(11):1535-7. doi: 10.1002/art.24201. No abstract available.

2.

Association of incident gout and mortality in dialysis patients.

Cohen SD, Kimmel PL, Neff R, Agodoa L, Abbott KC.

J Am Soc Nephrol. 2008 Nov;19(11):2204-10. doi: 10.1681/ASN.2007111256. Epub 2008 May 28.

3.

Comparison of drug adherence rates among patients with seven different medical conditions.

Briesacher BA, Andrade SE, Fouayzi H, Chan KA.

Pharmacotherapy. 2008 Apr;28(4):437-43. doi: 10.1592/phco.28.4.437.

4.

Medication adherence of patients with selected rheumatic conditions: a systematic review of the literature.

Harrold LR, Andrade SE.

Semin Arthritis Rheum. 2009 Apr;38(5):396-402. doi: 10.1016/j.semarthrit.2008.01.011. Epub 2008 Mar 12. Review.

5.

Disease-related and all-cause health care costs of elderly patients with gout.

Wu EQ, Patel PA, Yu AP, Mody RR, Cahill KE, Tang J, Krishnan E.

J Manag Care Pharm. 2008 Mar;14(2):164-75.

6.

Quality of care in gout: from measurement to improvement.

Mikuls TR.

Clin Exp Rheumatol. 2007 Nov-Dec;25(6 Suppl 47):114-9. Review.

PMID:
18021516
7.

Lowering serum uric acid levels: what is the optimal target for improving clinical outcomes in gout?

Perez-Ruiz F, Lioté F.

Arthritis Rheum. 2007 Oct 15;57(7):1324-8. Review. No abstract available.

8.

Motivational interviewing: an evidence-based approach to counseling helps patients follow treatment recommendations.

Levensky ER, Forcehimes A, O'Donohue WT, Beitz K.

Am J Nurs. 2007 Oct;107(10):50-8; quiz 58-9. Review.

PMID:
17895731
9.

Uric acid lowering therapy: prescribing patterns in a large cohort of older adults.

Solomon DH, Avorn J, Levin R, Brookhart MA.

Ann Rheum Dis. 2008 May;67(5):609-13. Epub 2007 Aug 29.

PMID:
17728328
10.

Quality of care for gout in the US needs improvement.

Singh JA, Hodges JS, Toscano JP, Asch SM.

Arthritis Rheum. 2007 Jun 15;57(5):822-9.

11.

British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout.

Jordan KM, Cameron JS, Snaith M, Zhang W, Doherty M, Seckl J, Hingorani A, Jaques R, Nuki G; British Society for Rheumatology and British Health Professionals in Rheumatology Standards, Guidelines and Audit Working Group (SGAWG).

Rheumatology (Oxford). 2007 Aug;46(8):1372-4. Epub 2007 May 23. No abstract available.

PMID:
17522099
12.

Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations.

Roddy E, Zhang W, Doherty M.

Ann Rheum Dis. 2007 Oct;66(10):1311-5. Epub 2007 May 15.

13.

Gout and the risk of acute myocardial infarction.

Krishnan E, Baker JF, Furst DE, Schumacher HR.

Arthritis Rheum. 2006 Aug;54(8):2688-96.

14.

Gout medication treatment patterns and adherence to standards of care from a managed care perspective.

Sarawate CA, Brewer KK, Yang W, Patel PA, Schumacher HR, Saag KG, Bakst AW.

Mayo Clin Proc. 2006 Jul;81(7):925-34.

PMID:
16835972
15.

EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Zhang W, Doherty M, Pascual E, Bardin T, Barskova V, Conaghan P, Gerster J, Jacobs J, Leeb B, Lioté F, McCarthy G, Netter P, Nuki G, Perez-Ruiz F, Pignone A, Pimentão J, Punzi L, Roddy E, Uhlig T, Zimmermann-Gòrska I; EULAR Standing Committee for International Clinical Studies Including Therapeutics.

Ann Rheum Dis. 2006 Oct;65(10):1301-11. Epub 2006 May 17. Review.

16.

EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P, Gerster J, Jacobs J, Leeb B, Lioté F, McCarthy G, Netter P, Nuki G, Perez-Ruiz F, Pignone A, Pimentão J, Punzi L, Roddy E, Uhlig T, Zimmermann-Gòrska I; EULAR Standing Committee for International Clinical Studies Including Therapeutics.

Ann Rheum Dis. 2006 Oct;65(10):1312-24. Epub 2006 May 17. Review.

17.

Medication errors with the use of allopurinol and colchicine: a retrospective study of a national, anonymous Internet-accessible error reporting system.

Mikuls TR, Curtis JR, Allison JJ, Hicks RW, Saag KG.

J Rheumatol. 2006 Mar;33(3):562-6. Epub 2006 Feb 15.

PMID:
16482645
18.

Frequency and predictors of inappropriate management of recurrent gout attacks in a longitudinal study.

Neogi T, Hunter DJ, Chaisson CE, Allensworth-Davies D, Zhang Y.

J Rheumatol. 2006 Jan;33(1):104-9. Epub 2005 Nov 1.

PMID:
16267879
19.

Health literacy: the gap between physicians and patients.

Safeer RS, Keenan J.

Am Fam Physician. 2005 Aug 1;72(3):463-8. Review.

20.

Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD).

Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Saag KG.

Rheumatology (Oxford). 2005 Aug;44(8):1038-42. Epub 2005 May 3.

PMID:
15870145

Supplemental Content

Support Center